Shares of NCC rose over 5%, most in over three weeks. Trading volume is nearly thrice the 30-day average.
The rise comes after the company bagged four orders, aggregating to Rs 1,645 crore (exclusive of GST) in July 2022.
One of the orders, worth Rs 945 crore pertains to building division and two other others worth Rs 619 crore to Water & Environment division. The remaining order, worth Rs 81 crore is related to electrical division.
Of the 18 analysts tracking the company, 17 maintain 'buy' and one suggests 'hold'. The return potential of the stock is 56.5%.
Source: Exchange filing, Bloomberg
Total sales rise 8.3% to 175,916 units
Domestic sales rise 10.2% to 155,605 units
Sales in mini and compact segment rise 17% to 105,151 units
Sales of utility vehicles fall 28% to 23,272 units
Source: Exchange filing
Jet fuel prices have been cut by 11.75% to Rs 1,21,915.57 per kilolitre.
Commercial LPG prices were slashed by Rs 36 to Rs 1,976.5 per 19-kg cylinder.
This is the second cut for ATF in two weeks and fourth reduction for commercial LPG since May.
No change in the price of domestic cooking gas LPG.
Source: PTI
The MidCap and SmallCap indices outperformed their larger peers, rising over 1%. Barring Healthcare, all the other 18 sectoral indices compiled by BSE Ltd. advanced with Auto index suring 2.7%.
The market breadth is skewed in the favour of bulls. About 2,197 stocks rose, 1,148 fell and 199 remained unchanged.
Domestic commercial vehicle sales rise 56% to 12,715 units
Total sales, including exports, rise 58% to 13,625 units
Source: Exchange filing
Tata Motors’ total domestic sales jump 52% year-on-year to 78,978 units in July
Domestic passenger vehicle sales rise 57% to 47,505 units
Total commercial vehicle sales rise 43% to 34,154 units
Source: Exchange filing
M&M total passenger vehicles sales rise 33% year-on-year to 28,053 units in July
M&M total tractor sales fall 14% year-on-year to 23,307 units in July
Source: Exchange filing
Gross GST collections for July at Rs 1.48 lakh crore ; second highest since GST implementation, states Finance Ministry.
July gross GST collections stood at Rs 1,48, 995 crores.
CGST : Rs 25,751 crore, SGST : Rs 32,807 crore
IGST : Rs 79,518 crore(including Rs 41,420 crore collected on import of goods)
Cess : Rs 10,920 crore(including Rs 995 crore collected on import of goods).
Source: PIB
India Manufacturing PMI at 56.4 in July from 53.9 in June.
Sales and production grow at fastest rates since last November.
Input costs inflation softens to a 11-month low
Source: IHS Markit
The market breadth is skewed in the favour of bulls. About 1,624 stocks rose, 887 fell and 124 remainded unchanged.
Yield on the 10-year bond fell 3bps to 7.29%.
The 10-year bond yield rose 3 bps to 7.34% before reversing gains.
Source: Bloomberg
U.S. Dollar Index at 105.8
U.S. 10-year bond yield at 2.66% on Friday
Brent crude down 0.8% to $103.1 per barrel
Nymex crude at $97.7 per barrel
SGX Nifty gains 1.28% to 17,280 as of 6:40 a.m
Bitcoin down 1.8% at $23,371.1
Source: Bloomberg
Indian currency appreciated 15 paise (0.19%) to 79.12, at the open.
Source: Bloomberg
Yes Bank: The bank approved proposal to raise Rs 8,898.47 crore from Carlyle Group and Advent International for 10% stake each.
NTPC: The company appointed Jaikumar Srinivasan, Director (Finance) as the Chief Financial Officer in place of Renu Narang with immediate effect.
Dr Reddy’s Laboratories: The company has entered into a licensing agreement with Princeton based Slayback Pharma, to acquire rights in Slayback’s Brimonidine Tartrate Ophthalmic Solution 0.025%, the private label equivalent of Lumify in U.S. Lumify is an over the counter eyedrop that can be used to relieve redness of the eye due to minor eye irritations. The agreement also provides the company exclusive rights to the product outside the U.S.
CEAT: The company will further invest Rs 3.5 crore in Greenzest Solar.
Cipla Q1 FY23 (Consolidated, YoY)
Revenue down 2% at Rs 5,375 crore Vs Rs 5,504 crore (Bloomberg estimate: Rs 5,459 crore)
EBITDA down 15% to Rs 1,143 crore from Rs 1,346 crore (Bloomberg estimate: Rs 1,062 crore)
EBITDA margins at 21.3% Vs 24.5% (Bloomberg estimate: 19.4%)
Net profit down 4% at Rs 686 crore Vs Rs 715 crore (Bloomberg estimate: Rs 628 crore)
Torrent Pharmaceuticals Q1 FY23 (Consolidated, YoY)
Revenue up 10% at Rs 2,347 crore Vs Rs 2,134 crore (Bloomberg estimate: Rs 2305.4 crore)
EBITDA up 5% at Rs 712 crore Vs Rs 677 crore (Bloomberg estimate: Rs 664.8 crore)
EBITDA margin 30% Vs 32%
Net profit up 7% at Rs 354 crore Vs Rs 330 crore (Bloomberg estimate: Rs 332 crore)
DLF Q1 FY23 (Consolidated, YoY)
Revenue up 26.5% at Rs 1,441.63 crore Vs Rs 1,139.53 crore (Bloomberg estimate: Rs 1,459.9 crore)
EBITDA up 5% at Rs 413.66 crore Vs Rs 395.44 crore (Bloomberg estimate: Rs 535 crore)
EBITDA margin 29% Vs 35%
Net profit up 39% at Rs 469.57 crore Vs Rs 337.1 crore (Bloomberg estimate: Rs 569.8 crore)
Cholamandalam Investment and Finance Q1 FY23 (Consolidated, YoY)
Revenue up 12% at Rs 2,770.02 crore Vs Rs 2,481.74 crore
EBITDA up 21% at Rs 1,896.10 crore Vs Rs 1560.98 crore
EBITDA margin 68% Vs 63%
Net profit up 71% at Rs 562.01 crore Vs Rs 328.55 crore
Metro Brands Q1 FY23 (Consolidated, QoQ)
Revenue up 26% at Rs 507.95 crore Vs Rs 403.16 crore
EBITDA up 41% at Rs 182.87 crore Vs Rs 129.84 crore
EBITDA margin 36% Vs 32%
Net profit up 52% at Rs 104.76 crore Vs Rs 68.78 crore
U.S. futures fell and Asian stocks were mixed on Monday, amid challenges swirling around China and a reminder from Federal Reserve officials that their key objective is to fight high inflation.
S&P 500 and Nasdaq 100 futures shed about 1%, while bourses in Japan, South Korea and Australia made modest headway. The caution follows the best month for global shares since 2020, which pared their slump this year to 16%.
At 7:00 a.m., the Singapore-traded SGX Nifty—an early barometer of India's benchmark Nifty 50—was trading 0.20% higher at 17,200 points.
The dollar was steady, oil retreated and Bitcoin slid